Quimi Daphne

Average Profitability
74.63%
Insider Buys Quantity
6
Insider Buys Sum
$285,951.61
Insider Sells Quantity
21
Insider Sells Sum
$2.55M

Insider Activity of Quimi Daphne

According to the SEC Form 4 filings, Quimi Daphne, being in a position of

  1. director at Amylyx Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 5000 shares for $9,436, and sold 0 shares,
    over all time since 2024-05-14, has bought 5000 shares for $9,436, and sold 0 shares.

The largest purchase of all time was on 2014-09-29 and amounted to 21476 shares of Amicus Therapeutics, Inc. for $130,931.

The largest sale of all time was on 2020-01-09 and amounted to 30000 shares of Amicus Therapeutics, Inc. for $297,903.

Biography of Quimi Daphne

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $17,0933100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2024-09-12PurchaseCentury Therapeutics, Inc.
IPSC
director
5,000
0.0059%
$1.53$7,657-21.1%
2024-05-15PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
director
2,250
0.0011%
$1.89$4,252+75.27%
2024-05-14PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
director
2,750
0.0014%
$1.89$5,184+70.05%
2023-01-18SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
6,923
0.0024%
$13.00$89,999-6.56%
2023-01-17SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0017%
$12.49$62,445-1.45%
2022-09-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
4,397
0.0015%
$11.29$49,621+2.94%
2022-08-05SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,798
0.002%
$12.00$69,576-3.16%
2022-06-17SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
4,396
0.0014%
$9.00$39,564+22.83%
2020-12-21SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0019%
$24.09$120,474-56.42%
2020-10-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0019%
$14.02$70,099-23.22%
2020-07-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
13,744
0.0053%
$15.47$212,651-6.85%
2020-01-09SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
30,000
0.012%
$9.93$297,903+44.42%
2018-03-09SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
17,500
0.007%
$10.48$183,400-11.84%
2018-03-01SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
16,298
0.0059%
$9.11$148,436-6.9%
2018-01-02SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
16,000
0.0075%
$12.54$200,603-6%
2017-10-12SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
14,000
0.0075%
$12.23$171,210+1.4%
2016-11-09SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
8,546
0.0035%
$8.00$68,368-3.86%
2015-10-01SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
22,500
0.0102%
$7.79$175,323-48.55%
2015-09-14SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
5,000
0.0042%
$18.08$90,400-60.89%
2015-07-01SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
5,200
0.0044%
$13.98$72,700-43.01%
Total: 27
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.